Bionic is a portmanteau from biology and electronics and is often confused with the word “Cyborg,” which describes a being with organic and mechatronic body parts. Bionics, or biologically inspired engineering, is the application of concepts and systems found in nature to design systems and products. With advancements in physiotherapy, robotics and medicine, bionic engineering is poised to find applications in healthcare.Source: Wikipedia.
Bionics is a fast-expanding medical field set to fulfill a substantial need. Our Bionic ETF offers one of the few ways to invest in a diversified portfolio of companies.
Today the companies underlying the Bionic ETF specialize in a range of fields, from heart valves to medical implants and diabetes monitoring devices. They include Edwards Lifesciences, a leader in artificial heart valves; Medtronic, which makes insulin pumps and pacemakers; and Stryker Corp, known for its joint replacements. As the new interfaces between man and machine evolve, so will the ETF’s holdings.
DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader in diabetes care technology. Dexcom simplifies and improves diabetes management around the world.
Stryker is one of the world’s leading medical technology companies. They offer innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes.
Medtronic Inc. is one of the world's market leaders in medical technology. The company focuses primarily on developing and manufacturing products for use in cardiology, cardiac surgery, ENT surgery, diabetology, neurology, neurosurgery, spinal surgery, anesthesiology, gastroenterology, urology, orthopedics and emergency medicine. The wide range of products includes pacemakers, cardiac monitors, catheters, drug pump systems and programming devices. The company's products are sold in around 150 countries.
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. The company partners with clinicians to develop innovative technologies in structural heart disease and critical care monitoring that enable them to save and enhance lives.
The company specializes in developing, manufacturing and marketing orthopedic and dental implants for reconstruction, spinal implants and trauma products.
Lower risk: Typically lower reward
Higher risk: Typically higher reward
It exists when a particular financial instrument is difficult to purchase or sell. If the relevant market is illiquid, it may not be possible to initiate a transaction or liquidate a position at an advantageous or reasonable price or at all.
The prices of the securities in the Fund are subject to the risks associated with investing in the securities market, including general economic conditions and sudden and unpredictable drops in value. An investment in Bionic ETF may lose money.
The Fund’s assets may be concentrated in one or more particular sectors or industries. Bionic ETF may be subject to the risk that economic, political or other conditions that have a negative effect on the relevant sectors or industries will negatively impact the Fund's performance to a greater extent than if the Fund’s assets were invested in a wider variety of sectors or industries.
For more information on risks, please see the “Risk Factors” section of the relevant Fund’s prospectus, available on www.vaneck.com.